1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis
(
- Contribution to journal › Article
- 2022
-
Mark
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort
(
- Contribution to journal › Article
-
Mark
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity : Findings from the EMAS cohort
(
- Contribution to journal › Article
- 2021
-
Mark
SARS-CoV-2, Testosterone and frailty in males (PROTEGGIMI) : A multidimensional research project
(
- Contribution to journal › Article
-
Mark
Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress—Prevalence and Clinical Correlates : Results From the European Male Ageing Study
(
- Contribution to journal › Article
-
Mark
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)
(
- Contribution to journal › Article
- 2019
-
Mark
Sperm recovery and ICSI outcomes in men with non-obstructive azoospermia : a systematic review and meta-analysis
(
- Contribution to journal › Article
- 2018
-
Mark
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism : Prospective results from the EMAS
(
- Contribution to journal › Article
-
Mark
Elevated luteinizing hormone despite normal testosterone levels in older men-natural history, risk factors and clinical features
(
- Contribution to journal › Article
- 2016
-
Mark
The androgen receptor gene CAG repeat in relation to 4-year changes in androgen-sensitive endpoints in community-dwelling older European men
(
- Contribution to journal › Article